{
    "Trade/Device Name(s)": [
        "BioPlex\u00ae 2200 APLS IgG Kit",
        "BioPlex\u00ae 2200 APLS IgG Calibrator Set",
        "BioPlex\u00ae 2200 APLS IgG Control Set",
        "BioPlex\u00ae 2200 APLS IgA Kit",
        "BioPlex\u00ae 2200 APLS IgA Calibrator Set",
        "BioPlex\u00ae 2200 APLS IgA Control Set",
        "BioPlex\u00ae 2200 Antiphospholipid Syndrome IgG and IgA Kits",
        "BioPlex\u00ae 2200 Antiphospholipid Syndrome IgG and IgA Calibrator Sets",
        "BioPlex\u00ae 2200 Antiphospholipid Syndrome IgG and IgA Control Sets"
    ],
    "Submitter Information": "Bio-Rad Laboratories, Inc. BioPlex Division",
    "510(k) Number": "K103834",
    "Predicate Device Reference 510(k) Number(s)": [
        "K022992",
        "K022990",
        "K013080",
        "K013079"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MID",
        "MSV",
        "JIX",
        "JJX"
    ],
    "Summary Letter Date": "March 16, 2012",
    "Summary Letter Received Date": "March 19, 2012",
    "Submission Date": "March 28, 2012",
    "Regulation Number(s)": [
        "21 CFR 866.5660",
        "21 CFR 862.1150",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Multiple autoantibodies immunological test system",
        "Calibrator",
        "Quality control material (Assayed and Unassayed)"
    ],
    "Analyte Class(es)": [
        "immunology",
        "autoimmune",
        "chemistry"
    ],
    "Analyte(s)": [
        "IgG antibody to Cardiolipin",
        "IgA antibody to Cardiolipin",
        "IgG antibody to Beta-2 Glycoprotein I",
        "IgA antibody to Beta-2 Glycoprotein I"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Lithium heparin tube",
        "Sodium heparin tube",
        "Sodium citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "BioPlex\u00ae 2200 System"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex flow immunoassay"
    ],
    "Methodologies": [
        "Immunoassay",
        "Semi-quantitative antibody detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Reagent",
        "System",
        "Instrument",
        "Platform"
    ],
    "Document Summary": "FDA 510(k) summary for BioPlex\u00ae 2200 Antiphospholipid Syndrome IgG and IgA multiplex flow immunoassay kits for detection of antibodies to Cardiolipin and Beta-2 Glycoprotein I",
    "Indications for Use Summary": "Aid in diagnosis of primary and secondary Antiphospholipid Syndrome (APS), including cases secondary to systemic lupus erythematosus (SLE), via semi-quantitative detection of IgG and IgA antibodies to Cardiolipin and Beta-2 Glycoprotein I in human serum and plasma using the BioPlex 2200 System",
    "fda_folder": "Immunology"
}